Small supernumerary marker chromosomes cannot be accurately identified by G-banding, and the related phenotypes vary greatly. It is essential to specify the origin, size, and gene content of marker chromosomes using molecular cytogenetic techniques. Herein, three fetuses with marker chromosomes were initially identified by G-banding. Single nucleotide polymorphism array and fluorescence hybridization were performed to characterize the origins of the marker chromosomes. The karyotypes of the three fetuses were 47,XY,+mar, 46,X,+mar[32]/45,X[68], and 45,X[62]/46,X,+mar[9]. In case 1, the karyotype was confirmed as 47,XY,+ idic(22)(q11.2). Therefore, the sSMC originated from chromosome 22 and was associated with cat eye syndrome. In case 2, the marker chromosome derived from ring chromosome X, and the karyotype was interpreted as 45,X[68]/46,X,+r(X)(p11.1q21.31)[32]. Meanwhile, the karyotype of case 3 was defined as 45,X[62]/46,X,idic(Y)(q11.2) and the marker chromosome originated from chromosome Y. Case 1 continued the pregnancy, whereas the other two pregnancies underwent elective termination. The detailed characterization of marker chromosomes can facilitate informed decision making, prevent uncertainty, and provide proper prognostic assessments. Our findings emphasize the importance for combining cytogenetic and molecular genetic techniques in marker chromosome characterization.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880375 | PMC |
http://dx.doi.org/10.18632/aging.202220 | DOI Listing |
Front Plant Sci
January 2025
Institut Sénégalais de Recherches Agricoles (ISRA/Centre d'Etude Regional pour l'Amélioration de l'Adaptation à la Sécheresse (CERAAS), Thies, Senegal.
Early leaf spot (ELS), caused by (syn. ), is a highly damaging peanut disease worldwide. While there are limited sources of resistance in cultivated peanut cultivars, wild relatives carry alleles for strong resistance, making them a valuable strategic resource for peanut improvement.
View Article and Find Full Text PDFBMJ Oncol
October 2023
Clinical Genetics, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Objective: In England, through the Genomic Medicine Service Alliances (GMSAs), a national transformation project aims to embed robust pathways to deliver universal Lynch syndrome (LS) testing for patients with colorectal and endometrial cancers. Prior to commencement of the project, there was evidence of variation and low testing levels in eligible patients which is consistent with other health systems; however, we believe this is amenable to systematic improvement with responsibility for testing delivery by local cancer teams supported by regional infrastructure.
Methods And Analysis: A project team and national oversight group was formed in May 2021 with membership including 21×cancer alliances, 7×GMSAs, charities and other stakeholders who agreed key performance indicators.
BMJ Oncol
December 2023
NHC Key Laboratory of Glycoconjugate Research, Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Objective: , a representative tumour suppressor gene with sex bias, is frequently altered in urothelial carcinoma (UC). The specific impacts of mutations on gender-based clinical outcomes in UC remain poorly understood.
Methods And Analysis: We enrolled 2438 patients with UC from seven independent real-world cohorts possessing comprehensive clinical and genomic data.
BMJ Oncol
February 2024
Nuffield Department of Medicine, Old Road Campus, Headington, University of Oxford, Oxford, UK.
BMJ Oncol
January 2024
Department of Internal Medicine, College of Medicine, The Ohio State University, Columbus, Ohio, USA.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!